| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| VGK84501B |
InVivoMAb Anti-Blood group H antigen/Globo H Antibody (R28) |
1mg |
$1,705.00
|
 |
BUY
|
| VVV02903A |
InVivoMAb Anti-HCMV/HHV5 gB Neutralizing Antibody(1G2) |
100 µg |
$475.00
|
 |
BUY
|
| VVV02903B |
InVivoMAb Anti-HCMV/HHV5 gB Neutralizing Antibody(1G2) |
1.0 mg |
$1,715.00
|
 |
BUY
|
| VHV22901A |
InVivoMAb Anti-HMPV F/Fusion glycoprotein F0 (MPV467) |
100µg |
$475.00
|
 |
BUY
|
| VHV22901B |
InVivoMAb Anti-HMPV F/Fusion glycoprotein F0 (MPV467) |
1mg |
$1,705.00
|
 |
BUY
|
| VHB63001A |
InVivoMAb Anti-Human GDF11/BMP11 (Iv0062) |
100 µg |
$475.00
|
 |
BUY
|
| VHB63001B |
InVivoMAb Anti-Human GDF11/BMP11 (Iv0062) |
1 mg |
$1,715.00
|
 |
BUY
|
| VHH28801A |
InVivoMAb Anti-Human IL17A (Iv0029) |
100 µg |
$475.00
|
 |
BUY
|
| VHH28801B |
InVivoMAb Anti-Human IL17A (Iv0029) |
1 mg |
$1,715.00
|
 |
BUY
|
| VVV03806A |
InVivoMAb Anti-Influenza A virus HA/Hemagglutinin (FLD21.140) |
100 µg |
$475.00
|
 |
BUY
|
| VVV03806B |
InVivoMAb Anti-Influenza A virus HA/Hemagglutinin (FLD21.140) |
1 mg |
$1,670.00
|
 |
BUY
|
| VVV24001A |
InVivoMAb Anti-Influenza A virus Neuraminidase/NA (1G01) |
100 µg |
$475.00
|
 |
BUY
|
| VVV24001B |
InVivoMAb Anti-Influenza A virus Neuraminidase/NA (1G01) |
1 mg |
$1,670.00
|
 |
BUY
|
| VVV07505A |
InVivoMAb Anti-MERS-CoV RBD (m336) |
100 µg |
$475.00
|
 |
BUY
|
| VVV07505B |
InVivoMAb Anti-MERS-CoV RBD (m336) |
1 mg |
$1,670.00
|
 |
BUY
|
| VVV07501B |
InVivoMAb Anti-MERS-CoV RBD (S41) |
1 mg |
$1,670.00
|
 |
BUY
|
| VVV07501A |
InVivoMAb Anti-MERS-CoV RBD (S41) |
100 µg |
$475.00
|
 |
BUY
|
| VVV08104A |
InVivoMAb Anti-Nipah virus/NiV F/Fusion glycoprotein F0 Antibody (2D3) |
100 µg |
$475.00
|
 |
BUY
|
| VVV08104B |
InVivoMAb Anti-Nipah virus/NiV F/Fusion glycoprotein F0 Antibody (2D3) |
1.0 mg |
$1,670.00
|
 |
BUY
|
| VVV08103A |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (1A9) |
100 µg |
$475.00
|
 |
BUY
|
| VVV08103B |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (1A9) |
1.0 mg |
$1,670.00
|
 |
BUY
|
| VVV08102B |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (1H8) |
1.0 mg |
$1,670.00
|
 |
BUY
|
| VVV08102A |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (1H8) |
100 µg |
$475.00
|
 |
BUY
|
| VVV08101B |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (4H3) |
1.0 mg |
$1,670.00
|
 |
BUY
|
| VVV08101A |
InVivoMAb Anti-Nipah virus/NiV Prefusion Antibody (4H3) |
100 µg |
$475.00
|
 |
BUY
|
| VVV08106B |
InVivoMAb Anti-Nipah virus/NiV Prefusion Protein Antibody (1H1) |
1.0 mg |
$1,670.00
|
 |
BUY
|
| VVV08106A |
InVivoMAb Anti-Nipah virus/NiV Prefusion Protein Antibody (1H1) |
100 µg |
$475.00
|
 |
BUY
|
| VVV08105A |
InVivoMAb Anti-Nipah virus/NiV Prefusion Protein Antibody (2B12) |
100 µg |
$475.00
|
 |
BUY
|
| VVV08105B |
InVivoMAb Anti-Nipah virus/NiV Prefusion Protein Antibody (2B12) |
1.0 mg |
$1,670.00
|
 |
BUY
|
| VVV25902B |
InVivoMAb Anti-Poliovirus Capsid protein VP1 (19B) |
1 mg |
$1,670.00
|
 |
BUY
|
| VVV25902A |
InVivoMAb Anti-Poliovirus Capsid protein VP1 (19B) |
100 µg |
$475.00
|
 |
BUY
|
| VVV25901B |
InVivoMAb Anti-Poliovirus Capsid protein VP1 (C3) |
1 mg |
$1,670.00
|
 |
BUY
|
| VVV25901A |
InVivoMAb Anti-Poliovirus Capsid protein VP1 (C3) |
100 µg |
$475.00
|
 |
BUY
|
| VVV00311A |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0221) |
100 µg |
$475.00
|
 |
BUY
|
| VVV00311B |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0221) |
1 mg |
$1,715.00
|
 |
BUY
|
| VVV00312B |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0222) |
1 mg |
$1,715.00
|
 |
BUY
|
| VVV00312A |
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing (Iv0222) |
100 µg |
$475.00
|
 |
BUY
|
| VVV00315B |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0262) |
1.0 mg |
$1,715.00
|
 |
BUY
|
| VVV00315A |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0262) |
100 µg |
$475.00
|
 |
BUY
|
| VVV00316B |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0263) |
100 µg |
$1,715.00
|
 |
BUY
|
| VVV00316A |
InVivoMAb Anti-SARS-CoV-2 RBD (KP.2) Neutralizing (Iv0263) |
100 µg |
$475.00
|
 |
BUY
|
| VVV00313A |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C121) |
100 µg |
$475.00
|
 |
BUY
|
| VVV00313B |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C121) |
1.0 mg |
$1,715.00
|
 |
BUY
|
| VVV00314A |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C135) |
100 µg |
$475.00
|
 |
BUY
|
| VVV00314B |
InVivoMAb Anti-SARS-CoV-2 RBD Neutralizing (C135) |
1.0 mg |
$1,715.00
|
 |
BUY
|
| FMF68810B |
Rat Anti-Mouse CD156b/ADAM17 (A12) mAb |
100 µg |
$430.00
|
 |
BUY
|
| FMF68810A |
Rat Anti-Mouse CD156b/ADAM17 (A12) mAb |
50 µg |
$280.00
|
 |
BUY
|
| DHJ69201A |
Research Grade Anti-Human TREM2 (aI002) |
100 ug |
$475.00
|
 |
BUY
|
| DHJ69201B |
Research Grade Anti-Human TREM2 (aI002) |
1.0 mg |
$1,715.00
|
 |
BUY
|
| DHJ45501A |
Research Grade Vixarelimab |
100 ug |
$420.00
|
 |
BUY
|
| DHJ45501B |
Research Grade Vixarelimab |
1.0 mg |
$1,520.00
|
 |
BUY
|